Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography
© Yamashita et al.; licensee BioMed Central. 2015
Received: 28 June 2014
Accepted: 16 December 2014
Published: 8 January 2015
The purpose of the present study was to quantify the inter-fractional motion of the rectum and the rectal and bladder volumes using CBCT scans taken during chemoradiation therapy (CRT) for rectal cancer. Also, assessment was made for a better margin for simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) for rectal cancer.
Methods and materials
There were 32 patients in this study undergoing preoperative CRT for rectal cancer. Each rectum and bladder was contoured on all planning CTs and CBCTs (day 1, 7, 13, 19, 25). The target volume was configured by adding margins (0, 3, 5, 7, 10, and 15 mm) to the rectum on planning CT. The respective percentage of rectal volume that exceeds the target volume was calculated for each of these margins. The percentage of bladder volume that exceeds the bladder volume in the planning CT and motion of the center of gravity of rectum were also analyzed.
Planning CTs and series of each 5 CBCTs for 32 patients were analyzed in this study. The rectal volume tended to shrink week after week. The mean values (± SD) in the 32 series per patient of the percentage of rectum on the CBCTs exceeding target volume in which the margins of 0, 3, 5, 7, 10, and 15 mm were added to the rectum on planning CT were 20.7 ± 12.5%, 7.2 ± 8.3%, 3.9 ± 5.9%, 2.1 ± 3.9%, 0.7 ± 1.8%, and 0.1 ± 0.3%, respectively. No association was seen between the percentage of changes of bladder volume and motion of rectal centroid.
In this study, we estimated the motion of the rectum using planning CT and CBCT. Ten to fifteen mm is a sufficient margin for the rectum during SIB-IMRT for rectal cancer in the supine position.
Neoadjuvant concurrent chemoradiation therapy (CCRT) has become the standard for locally advanced rectal cancer. Previous studies showed that preoperative CCRT reduced recurrence rate and increased sphincter preservation rate when compared to postoperative CCRT [1,2]. Intensity modulated radiation therapy (IMRT) has gradually replaced traditional four-field box radiotherapy in rectal cancer treatment because it improves dose distribution and reduces bowel exposure [3,4]. Volumetric modulated arc therapy (VMAT), a recently developed technique involving arc-IMRT delivery, has been shown to further improve dose conformity and to reduce the dose to the organ at risk [5,6].
Preoperative CRT for rectal cancer is important because local control for pelvis is closely related to cure in rectal cancer. Additionally, rectal cancer could be curable even if there are a few lung or liver metastases called as oligometastases or oligo-recurrence [7,8] after local therapy like surgery, stereotactic radiotherapy, or radiofrequency ablation .
It is clear that the quantification of rectal tumor and mesorectal motion is required to improve the certainty of target volume (TV) coverage. Similarly, information on normal tissue placement throughout a treatment course is necessary to estimate the true risk to these organs. Rectal and other organ motion is most critical in delivering radiation therapy (RT) when the target volume conforms more closely to the rectum and the dose reaches a more critical level. A careful assessment of the internal margins, which must be added to the TV to compensate for physiologic variations in the size, shape, and position of the TV during RT, would contribute toward optimization of the therapeutic ratio.
The purpose of this study was to quantify the rectal movement as well as the changes in rectal and bladder volumes using cone-beam computed tomography (CBCT) scans taken during CCRT for rectal cancer.
Materials and methods
Patients & eligibility
The patients were consecutive cases who received preoperative CRT by VMAT IMRT using a simulataneous integrated boost (SIB) for stage II-III rectal cancer with invasion to the rectum/below the peritoneal reflection (Rb) from January 2012 to August 2013 in our department. The name of the body is “analysis about organ motion during radiation therapy for body tumor”. The reference number is No. 2613. For dose fractionation, the schedule was 45 Gy in 25 fractions at 95% dose for elective volume and 55 Gy in 25 fractions at 95% dose for the boosted volume. The chemotherapy consisted of 300 mg/m2/day of oral tegafur/uracil (UFT) and 75 mg per day of Leucovorin (UZEL) on the same day as RT for 25 days.
The patients’ eligibility criteria included: 1) histologically confirmed rectal adenocarcinoma, 2) clinically diagnosed T3-4 or node-positive disease by use of trans-rectal ultrasound, 3) no distant metastasis, 4) no prior chemotherapy, 5) no prior RT in pelvic cavity, 6) curative aim of total mesorectal excision (TME) after CCRT, 7) no other simultaneous malignancies, 8) lower edge of primary tumor invading lower rectum (Rb), 9) over 18 years old, and 10) having PET/CT examination before preoperative therapy.
Patient and tumor characteristics
Distance from AV
Rectal volume on planning CT
Bladder volume on planning CT
Image assessment & analysis
The planning CT was acquired before RT and CBCTs were acquired once per week during RT for a total of 5 times for each patient. Rectal cancer patients were treated in the dorsal position. All of the planning CTs and CBCTs were also taken in the dorsal position. Before all of the planning CT and CBCT scans were taken, all patients were instructed to collect urine for two hours and were not regularly given laxatives to empty the intestine. All CBCT images for each week and each patient were imported into a Pinnacle3 treatment-planning workstation (Philips Healthcare, Andover, MA; ADAC, Milpitas, CA). The evaluations of organ motion and volume changes were performed on a Pinnacle3.
CT images for treatment planning were acquired using Aquillion TMLB (TOSHIBA, Tokyo, Japan). CT images were acquired with 2-mm-thick slices. The CBCT images acquired immediately before treatment were applicable for the accurate localization of the target. The pre-treatment 3D CBCT images were acquired with kV imaging parameters of a beam of 120 kVp and 20 mA per 20 ms at an axial field length of 20 cm with a bow-tie filter immediately before daily treatment. The typical number of frames was approximately 650 in a pre-treatment CBCT scan. In the registration procedure, Chamfer matching (bone matching) was used.
The caudal edge of the rectum was defined as the anal verge and the rectum was contoured up to the slice wherein the anterior wall of the intestine started to shift into the ventral side of the cranial edge and, in sum, up to the sigmoid colon.
The percentages of changes of the bladder volumes and motions of the center of gravity of the rectum were also analyzed. The changing percentage was calculated as bladder volume for each CBCT per bladder volume on planned CT. The motion of the center of gravity of the rectum was calculated as the anterior-posterior, left-right, and cranio-caudal position gaps between the coordinates of the center of gravity of the rectum on each CBCT and rectal centroid on planned CT.
Student’s t test and Fisher’s exact test (one tailed) were used to test the significance of differences between cohorts. Pearson’s product-moment correlation coefficient was used to examine the relationship between the bladder volume and the motion of the rectal center of gravity.
Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
The mean rectal motion (± SD) of the center of gravity in 32 series of CT sets per patient was +5.6 (±7.3) mm in the cranio-caudal direction, -2.2 (±5.0) mm in the ventro-dorsal direction, and -0.9 (±2.6) mm in the right-left direction, respectively. The mean value (± SD) of 32 SDs in the respective 32 patients was 3.8 (±2.1) mm in the cranio-caudal direction, 2.7 (±2.8) mm in the ventro-dorsal direction, and 1.3 (±0.6) mm in the right-left direction, respectively. The maximum and minimum values of 32 SD sets were 8.3 mm and 0.8 mm in the cranio-caudal direction, 17.0 mm and 1.0 mm in the ventro-dorsal direction, and 2.5 mm and 0.2 mm in the right-left direction, respectively.
The purpose of the present study was to quantify the motion of the rectum using CBCT during neoadjuvant CCRT for rectal cancer, and to consider a better margin for SIB-IMRT for rectal cancer. This study addressed positional and volumetric changes in rectal and bladder volumes in patients receiving CRT for rectal cancer. The work is original with respect to rectal cancer and patient positioning during CRT. Several studies have reported on rectal motion based on CBCT [10,11]. However, to the best of our knowledge, this is the first study to evaluate the percentage of rectum motion on the CBCTs exceeding target volume in planning CT during neoadjuvant CRT for rectal cancer.
The tendency for a reduction of the rectal volume during the weekly treatment period was seen in this study. Some studies, including our present one, have seen a decrease in the rectal volume [12,13]. As for the cause of the decreases in rectal volume in this study, the reduction of rectal tumor and the tendency for the treatment to inhibit stool formation were considered. However, it was pointed out that the decrease of the rectal volume occurs even when examining rectal change during RT for prostate cancer. The possibility remains that other factors influence the decreases of rectal volume.
In addition, in regard to the percentage of rectal volume exceeding the planning CT on CBCT, those cases with tumor less than 3 cm from the AV had significantly smaller percentages than cases with more than 5 cm. In pursuing the question of the influence of inter-fraction motion, Chong et al.  analyzed the motion by dividing the rectum into upper, middle, and lower parts and found that rectal motion was smallest in the lower part. Our results concurred with these observations.
In this analysis the change of bladder volume did not correlate with the motion of the rectal center of gravity. That the patients were irradiated in a urine collection state for 2 hours before treatment in our institution may be a factor, and resulted in a smaller percentage of change of the daily bladder volume.
After analyzing how much of the rectum during RT is covered by the margins added to planning CT in this study, the percentages found to protrude were 0.7% +/-1.8% in a 10 mm margin and 0.1% +/- 0.3% in a 15 mm margin. Judging from this result, the margin around 10-15 mm to the rectum was considered sufficient. This result was similar to previous reports of 14.2-17 mm for the anterior wall and 14.4-16 mm for the posterior wall .
However, in this study, motions of the rectum in the anterior, posterior, right and left directions were not analyzed. In addition, the past studies reported were of rectal motion in patients treated in the prone position, [10,11,14,15] whereas the rectal cancer patients in our institution were treated in the supine position. The optimal margin may change with posture during irradiation or motion directions of the rectal wall, and further studies will be necessary.
Although CBCT was used for analysis in this study, the image quality of CBCT scans were generally poor and easily affected by the internal gas. Further improvement of image quality in future CBCT studies will be expected to rigorously compare contours of CBCT images.
Our clinical result of pathological response rate was 60% at surgery of total mesorectal excision. The extended margins may have compensated for the movements and changes in volume of target organs. This will also need to be confirmed in future studies.
In this study, the motion of the rectum was estimated using planning CT and CBCT. Ten to fifteen mm is sufficient as a margin to the rectum during SIB-IMRT for rectal cancer in the supine position. However, the margin estimated in this study was calculated from the percentage of rectum motion on the CBCTs exceeding the planning CT, and the margin to each direction of the rectal wall was not examined. In the future, further detailed investigation is required on the difference in rectal motion according to the location of the rectal tumor above the AV. It is also necessary to examine individual margins to anterior-posterior and lateral directions.
- Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedView ArticleGoogle Scholar
- Roh MS, Colangelo LH, O’Connell MJ, Yothers G, Deutsch M, Allegra CJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124–30.PubMed CentralPubMedView ArticleGoogle Scholar
- Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, et al. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol. 2011;6:63.PubMed CentralPubMedView ArticleGoogle Scholar
- Nijkamp J, Doodeman B, Marijnen C, Vincent A, van Vliet-Vroegindeweij C. Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board. Radiother Oncol. 2012;102:22–9.PubMedView ArticleGoogle Scholar
- Vieillot S, Azria D, Lemanski C, Moscardo CL, Gourgou S, Dubois JB, et al. Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer. Radiat Oncol. 2010;5:92.PubMed CentralPubMedView ArticleGoogle Scholar
- Richetti A, Fogliata A, Clivio A, Nicolini G, Pesce G, Salati E, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol. 2010;5:14.PubMed CentralPubMedView ArticleGoogle Scholar
- Niibe Y, Chang JY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med. 2012;2012:261096.PubMed CentralPubMedView ArticleGoogle Scholar
- Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol. 2010;40:107–11.PubMed CentralPubMedView ArticleGoogle Scholar
- Seo YS, Kim MS, Yoo HJ, Jang WI. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol. 2014;20:2005–13.PubMed CentralPubMedView ArticleGoogle Scholar
- Chong I, Hawkins M, Hansen V, Thomas K, McNair H, O’Neill B, et al. Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2011;81:e431–8.PubMedView ArticleGoogle Scholar
- Nijkamp J, de Jong R, Sonke JJ, Remeijer P, van Vliet C, Marijnen C. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol. 2009;92:202–9.PubMedView ArticleGoogle Scholar
- Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:1321–9.PubMedView ArticleGoogle Scholar
- Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 1995;33:1109–19.PubMedView ArticleGoogle Scholar
- Nuyttens JJ, Robertson JM, Yan D, Martinez A. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys. 2002;53:497–503.PubMedView ArticleGoogle Scholar
- Tournel K, De Ridder M, Engels B, Bijdekerke P, Fierens Y, Duchateau M, et al. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys. 2008;71:934–9.PubMedView ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.